UPDATE: Evofem Biosciences stock soars 27% premarket on news of positive results in trial of drugs for STDs [MarketWatch]
Evofem Biosciences, Inc. (EVFM)
Last evofem biosciences, inc. earnings: 3/12 08:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
evofem.com
Company Research
Source: MarketWatch
UPDATE: Evofem Biosciences stock soars 27% premarket on news of positive results in trial of drugs for STDs Evofem Biosciences Inc. EVFM, +0.33% reported positive results in a mid-stage trial of a treatment for chlamydia and gonorrhea in women, sending its stock up 27% in premarket trade Monday. The San Diego-based company said a phase 2b study of amphora for preventing the two sexually transmitted diseases met its primary and secondary endpoints of reducing the risk of infection and showed it was safe and well tolerated. "In addition to resubmitting our New Drug Application to the U.S. FDA for Amphora for prevention of pregnancy, we also now have statistically significant evidence that Amphora can prevent acquisition of chlamydia and gonorrhea among women, two bacterial infections that are increasing at an alarming annual rate in the U.S.," Evofem Chief Executive Saundra Pelletier said in a statement. The U.S. Centers for Disease Control and Prevention said rates of infection for
Show less
Read more
Impact Snapshot
Event Time:
EVFM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EVFM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EVFM alerts
High impacting Evofem Biosciences, Inc. news events
Weekly update
A roundup of the hottest topics
EVFM
Sec Filings
- 3/28/24 - Form 8-K
- 3/27/24 - Form 10-K
- 3/27/24 - Form 8-K
- EVFM's page on the SEC website